Millions of Americans take an ACE inhibitor to assist curb their high vital sign — actually , these drugs are the foremost widely used antihypertensives in America.
However, a replacement international study of nearly 5 million patients is casting doubt on the notion that the drugs are as effective as another class of vital sign medicines. Common ACE inhibitors include drugs like benazepril, captopril, enalapril, fosinopril and lisinopril, among others.
The new study should “help guide physicians in their clinical decision-making,” said study author Dr. George Hripcsak. He’s chair of biomedical informatics at Columbia University’s College of Physicians and Surgeons, in ny City.
American College of Cardiology and American Heart Association guidelines recommend starting vital sign treatment with any drug from five different classes of medicines . Those classes include: thiazide diuretics; ACE inhibitors; angiotensin II receptor blockers (ARBs); dihydropyridine calcium channel blockers and non-dihydropyridine calcium channel blockers.
To find out how often these medicines are prescribed, Hripcsak’s team tracked data on nearly 5 million patients across four countries — Germany, Japan, South Korea and therefore the us .